Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. Since 1898, our doctors and scientists have been engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Weill Cornell Medicine's powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist.
Dr. John Leonard, associate dean of clinical research and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, won the Lymphoma Research Foundation Distinguished Service Award. Dr. Leonard served as chair of the foundation’s Scientific Advisory Board and oversaw the creation of the Lymphoma Clinical Research Mentoring Program, a mentoring and training program for early-career lymphoma researchers, and provided instrumental support in the creation of the Adolescent/Young Adult Lymphoma Initiative. The foundation is the nation’s largest lymphoma-focused health organization devoted to improving care through education and support services and improving outcomes through investment in research.
Dr. Art Sedrakyan, a professor of healthcare policy and research, has been named co-editor-in-chief of the newly launched healthcare journal BMJ Surgery, Interventions, & Health Technologies, an open-access journal that publishes original research on complex healthcare interventions. Intended to encourage higher standards of science and more rapid dissemination of new knowledge in the field, it provides a high-impact international platform for both early and later stage clinical studies as well as long-term assessment and surveillance studies that meet high standards of design and reporting. The journal launched May 7.
Dr. Maria Jasin, a professor in the Cell and Developmental Biology Program in the Weill Cornell Graduate School of Medical Sciences, has been awarded the Shaw Prize in Life Science and Medicine from the Shaw Prize Foundation. Dr. Jasin was honored for her research showing that localized double strand breaks in DNA stimulate recombination in mammalian cells. This seminal work was essential for and led directly to the tools enabling editing at specific sites in mammalian genomes.